BridgeMD
New treatment option for Cutaneous T-Cell Lymphoma
Official title MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
ClinicalTrials.gov ID: NCT05333367
What this study is testing
- What it's testing
- The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Adult patients
- Treated with ECP for at least 1 month, for control of GVHD in hematopoietic cell allograft (acute or chronic GVHD), treatment and control of cellular...
You likely can't join if
- people with limited legal capacity.
- people judged by the investigator to be unlikely to comply with study procedures
- people with no social security coverage.
- Pregnant women.
- people still in the exclusion period of another study, or according to the national registry of clinical trial participants.
The study team makes the final eligibility decision.
Where it's taking place
- Besançon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Besançon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.